Balyasny Asset Management
NRC icon

Balyasny Asset Management’s NRC Health Common Stock NRC Stock Holding History

Balyasny Asset Management’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,707
Closed -$464K – 2939
2024
Q1 		$464K Buy
11,707
+4,223
+56% +$167K ﹤0.01% 2084
2023
Q4 		$296K Buy
+7,484
New +$313K ﹤0.01% 2166

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balyasny Asset Management's NRC Position: Q2 2024 in Review

Balyasny Asset Management sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 11,707 shares — an estimated $464K sold.

Balyasny Asset Management first reported a position in NRC in Q4 2023 and held it in 2 quarters. The position peaked at $464K in Q1 2024. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Balyasny Asset Management reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 11,707 NRC Health Common Stock shares in Q2 2024, an estimated $464K.
  • Balyasny Asset Management first reported a position in NRC Health Common Stock in Q4 2023 and held it in 2 quarters.
  • Balyasny Asset Management's NRC Health Common Stock position peaked at $464K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.